Barclays Cuts Allegion (NYSE:ALLE) Price Target to $165.00

04 Apr 2026, 03:06 by Doug Wharley · The Cerbat Gem

Allegion (NYSE:ALLE – Free Report) had its price objective reduced by Barclays from $176.00 to $165.00 in a report issued on Wednesday,Benzinga reports. Barclays currently has an equal weight rating on the scientific and technical instruments company’s stock.

A number of other research analysts have also weighed in on the company. Weiss Ratings restated a “buy (b)” rating on shares of Allegion in a report on Wednesday, January 21st. JPMorgan Chase & Co. dropped their price target on shares of Allegion from $190.00 to $180.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Finally, Wells Fargo & Company cut their price target on shares of Allegion from $175.00 to $155.00 and set an “equal weight” rating on the stock in a report on Wednesday. Three analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $171.13.

Get Our Latest Analysis on Allegion

Allegion Stock Up 0.1%

Shares of NYSE ALLE opened at $141.16 on Wednesday. The stock has a market capitalization of $12.16 billion, a P/E ratio of 18.97, a P/E/G ratio of 3.05 and a beta of 1.02. The company has a 50-day moving average price of $157.76 and a 200-day moving average price of $163.87. Allegion has a 1 year low of $116.57 and a 1 year high of $183.11. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.84 and a quick ratio of 1.16.

Allegion (NYSE:ALLE – Get Free Report) last posted its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $1.94 earnings per share for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.07). The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.04 billion. Allegion had a return on equity of 38.06% and a net margin of 15.83%.The company’s revenue was up 9.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.86 EPS. Allegion has set its FY 2026 guidance at 8.700-8.900 EPS. On average, equities research analysts forecast that Allegion will post 7.77 EPS for the current fiscal year.

Allegion Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 13th were given a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 1.6%. This is a positive change from Allegion’s previous quarterly dividend of $0.51. The ex-dividend date was Friday, March 13th. Allegion’s dividend payout ratio (DPR) is currently 29.57%.

Insider Buying and Selling

In related news, Director Sue Main purchased 2,000 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were purchased at an average price of $149.61 per share, with a total value of $299,220.00. Following the acquisition, the director directly owned 2,000 shares of the company’s stock, valued at approximately $299,220. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven Mizell sold 1,000 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $161.51, for a total transaction of $161,510.00. Following the sale, the director owned 4,915 shares in the company, valued at approximately $793,821.65. This trade represents a 16.91% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.23% of the company’s stock.

Institutional Trading of Allegion

Hedge funds have recently bought and sold shares of the company. Hsbc Holdings PLC increased its holdings in shares of Allegion by 2.9% in the fourth quarter. Hsbc Holdings PLC now owns 34,469 shares of the scientific and technical instruments company’s stock worth $5,527,000 after buying an additional 956 shares during the period. Rockefeller Capital Management L.P. increased its stake in shares of Allegion by 16.3% in the fourth quarter. Rockefeller Capital Management L.P. now owns 19,372 shares of the scientific and technical instruments company’s stock worth $3,085,000 after buying an additional 2,717 shares during the period. PEAK6 LLC purchased a new stake in shares of Allegion during the fourth quarter worth about $366,000. Corient Private Wealth LLC boosted its holdings in shares of Allegion by 2.3% during the fourth quarter. Corient Private Wealth LLC now owns 7,413 shares of the scientific and technical instruments company’s stock worth $1,180,000 after purchasing an additional 170 shares during the period. Finally, Compound Planning Inc. grew its stake in shares of Allegion by 11.5% in the fourth quarter. Compound Planning Inc. now owns 2,515 shares of the scientific and technical instruments company’s stock worth $400,000 after purchasing an additional 259 shares during the last quarter. Institutional investors own 92.21% of the company’s stock.

Allegion Company Profile

(Get Free Report)

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is headquartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.